{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:49:07Z","timestamp":1791312547801,"version":"4.3.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.bone.2006.01.153","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T09:28:25Z","timestamp":1142328505000},"page":"S18-S22","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Once-monthly dosing: An effective step forward"],"prefix":"10.1016","volume":"38","author":[{"given":"D.M.","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2006.01.153_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00198-004-1612-7","article-title":"Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing","volume":"15","author":"Bauss","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2006.01.153_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.153_bib3","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1210\/jc.2004-1750","article-title":"Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study","volume":"90","author":"Reginster","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2006.01.153_bib4","first-page":"S97","article-title":"Successful prediction of the effect of once-monthly oral ibandronate on a marker of bone resorption using clinical trial simulation (CTS)","volume":"15","author":"Gieschke","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2006.01.153_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/0091270004267594","article-title":"Ibandronate: a clinical pharmacological and pharmacokinetic update","volume":"44","author":"Barrett","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2006.01.153_bib6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1359\/JBMR.050313","article-title":"Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study","volume":"20","author":"Miller","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.153_bib7","first-page":"1905","article-title":"ICH harmonized tripartite guideline. Statistical principles for clinical trials","volume":"18","year":"1999","journal-title":"Stat. Med."},{"key":"10.1016\/j.bone.2006.01.153_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1185\/030079904125003566","article-title":"Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis","volume":"20","author":"Harris","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bone.2006.01.153_bib9","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1359\/jbmr.2002.17.11.1988","article-title":"Two-year results of once-weekly administration of alendronate 70\u00a0mg for the treatment of postmenopausal osteoporosis","volume":"17","author":"Rizzoli","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.153_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00198-005-1957-6","article-title":"A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate","volume":"17","author":"Reginster","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2006.01.153_bib11","unstructured":"Reginster J-Y, Adami S, Lakatos P, et al. Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2-year results from the MOBILE study. Ann Rheum Dis, in press."},{"issue":"Suppl. 9","key":"10.1016\/j.bone.2006.01.153_bib12","first-page":"584","article-title":"Favorable upper gastrointestinal safety profile of ibandronate in patients with a history of gastrointestinal disorders or receiving concomitant NSAIDs","volume":"48","author":"Rosen","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2006.01.153_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2006.01.153_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6290","article-title":"Treatment of established osteoporosis: a systematic review and cost-utility analysis","volume":"6","author":"Kanis","year":"2002","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.bone.2006.01.153_bib15","unstructured":"Stevenson M, Lloyd-Jones M, Brazier J, Oakley J, Peters J, Brewer N, The clinical effectiveness and cost effectiveness of prevention and treatment of osteoporosis. Report commissioned by the NHS R&D HTA Programme, on behalf of the National Institute of Clinical Excellence; 2003."},{"key":"10.1016\/j.bone.2006.01.153_bib16","first-page":"31","article-title":"Women with postmenopausal osteoporosis express a preference for once-monthly versus once-weekly bisphosphonate treatment","volume":"30","author":"Simon","year":"2005","journal-title":"Female Patient"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2006.01.153_bib17","first-page":"S416","article-title":"BALTO I: women treated for osteoporosis rate preference and convenience for once-monthly ibandronate versus once-weekly alendronate","volume":"20","author":"Emkey","year":"2005","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T16:23:32Z","timestamp":1547742212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328206002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S8756328206002262"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2006.01.153","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}